Mizuho Raises Price Target For Salix Pharmaceuticals
Mizuho Securities Reiterates Buy on Questcor Pharmaceuticals on Stock Price Weakness
UPDATE: Mizuho Securities Upgrades Cubist Pharmaceuticals on Pending Acquisitions of Optimer and Trius
Avanir Shares Rebound As Analysts Offer Defense On Heels of 13% Drop